On 14 November 2015
Sword & Shield Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2015, to consider, approve & take on record the unaudited financial results of the Company along with Limited Review Report for the quarter and half year ended on 30 September 2015 as per Clause 41 of the Listing Agreement.Powered by Capital Market - Live News
